Marshall Wace North America’s Encompass Health EHC Stock Holding History

Marshall Wace North America’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.26M	Sell	21,032 -56,202	-73%	-$3.54M	0.01%	849
2021 Q2	$4.79M	Buy	77,234 +57,572	+293%	+$3.84M	0.02%	563
2021 Q1	$1.28M	Buy	19,662 +12,432	+172%	+$811K	0.01%	957
2020 Q4	$476K	Buy	+7,230	New	+$425K	﹤0.01%	1093
2020 Q1	–	Sell	-121,722	Closed	-$6.71M	–	1321
2019 Q4	$6.71M	Buy	121,722 +50,455	+71%	+$2.74M	0.03%	345
2019 Q3	$3.59M	Sell	71,267 -144,120	-67%	-$7.24M	0.02%	430
2019 Q2	$10.9M	Buy	215,387 +201,770	+1,482%	+$9.79M	0.07%	223
2019 Q1	$633K	Sell	13,617 -35,018	-72%	-$1.77M	﹤0.01%	752
2018 Q4	$2.39M	Buy	+48,635	New	+$2.77M	0.02%	396
2018 Q2	–	Sell	-266,033	Closed	-$12.1M	–	1463
2018 Q1	$12.1M	Sell	266,033 -141,931	-35%	-$6.08M	0.06%	353
2017 Q4	$16M	Sell	407,964 -387,564	-49%	-$14.7M	0.09%	275
2017 Q3	$29.1M	Buy	795,528 +90,894	+13%	+$3.24M	0.18%	148
2017 Q2	$26.9M	Buy	704,634 +533,320	+311%	+$19.5M	0.2%	133
2017 Q1	$5.86M	Buy	+171,314	New	+$5.63M	0.05%	362
2013 Q4	$8.45M	Buy	+318,666	New	+$8.87M	0.18%	134

Other funds holding EHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Marshall Wace North America's EHC Position: Q3 2021 in Review

Marshall Wace North America reduced its Encompass Health (EHC) stake by 73% in Q3 2021, selling an estimated $3.54M and leaving 21,032 shares worth $1.26M. The position accounts for 0.01% of the portfolio, ranked #849.

Marshall Wace North America first reported a position in EHC in Q4 2013 and has held it in 15 quarters since. The position peaked at $29.1M in Q3 2017. 436 funds tracked by Wall St. Rank hold EHC as of Q3 2021.

Marshall Wace North America held 21,032 shares of Encompass Health worth $1.26M as of Q3 2021.
Marshall Wace North America sold 56,202 Encompass Health shares in Q3 2021, an estimated $3.54M.
Encompass Health made up 0.01% of Marshall Wace North America's portfolio in Q3 2021, its #849 holding.
Marshall Wace North America first reported a position in Encompass Health in Q4 2013 and has held it in 15 quarters since.
Marshall Wace North America's Encompass Health position peaked at $29.1M in Q3 2017.
436 funds tracked by Wall St. Rank held Encompass Health as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.